New CDC guidelines for prevention of perinatal group B streptococcal disease [7]

Lancet

Volumn 361, Issue 9354, 2003, Pages 351-

  Jakobi, Peter ^a,b   Goldstick, Orly ^a,b   Sujov, Polo ^a,b   Itskovitz Eldor, Joseph ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; CORRELATION ANALYSIS; ECONOMIC ASPECT; ENTEROBACTERIACEAE; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; HEALTH CARE; HUMAN; INCIDENCE; LETTER; NEWBORN SEPSIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PUBLICATION; STANDARD; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; TREATMENT INDICATION; UNITED STATES;

EID: 0037464772     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12355-0     Document Type: Letter

References (5)

1. Jakobi P., Goldstick O., Sujov P., Itskovitz-Eldor J. New CDC guidelines for prevention of perinatal group B streptococcal disease. Lancet. 348:1996;969.
2. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Morb Mortal Wkly Rep 2002; 51: 1-22.
3. Jakobi P., Goldstick O., Sujov P., Itskovitz-Eldor J. Intrapartum prophylaxis for perinatal group B streptococcal disease: do the CDC guidelines apply in Israel? The Rambam experience. Israel J Obstet Gynecol. 11:2000;47-50.
4. Stoll B.J., Hansen N., Fanaroff A.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 347:2002;240-247.
5. Edwards R.K., Clark P., Sistrom C.L., Duff P. Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on gram-negative pathogens. Obstet Gynecol. 100:2002;534-539.